Inhibition of autoimmune Th17 cell responses by pain killer ketamine.

Lee, Jeong-Eun; Lee, Jung-Man; Park, Young-Jun; Kim, Byung-Seok; Jeon, Young-Tae; Chung, Yeonseok.

Lee JE; Laboratory of Immune Regulation, Institute of Pharmaceutical Sciences and College of Pharmacy, Seoul National University, Seoul, Republic of Korea.
Lee JM; BK21 plus program, College of Pharmacy, Seoul National University, Seoul, Republic of Korea.
Park YJ; Department of Anesthesiology and Pain Medicine, SMG-SNU Boramae Medical Center, Seoul, Republic of Korea.
Kim BS; Laboratory of Immune Regulation, Institute of Pharmaceutical Sciences and College of Pharmacy, Seoul National University, Seoul, Republic of Korea.
Jeon YT; Laboratory of Immune Regulation, Institute of Pharmaceutical Sciences and College of Pharmacy, Seoul National University, Seoul, Republic of Korea.
Chung Y; BK21 plus program, College of Pharmacy, Seoul National University, Seoul, Republic of Korea.

Oncotarget ; 8(52): 89475-89485, 2017 Oct 27.

Article en En | MEDLINE | ID: mdl-29163764